4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Vulvovaginal Atrophy: new trials by email Literature Review of Vulvovaginal Atrophy trials Research Report on Vulvovaginal Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy. Estrogen, dehydroepiandrosterone, Estrogen + probiotics - Vulvovaginal Atrophy, Breast Cancer | Phase 4 | Completed | University Hospital, Ghent | 31 | 2022-03-21 | 2026-08-13 |
| Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women vaginal estradiol 10 μg, vaginal DHEA 6.5 mg - Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause | Phase 4 | Completed | Angelica Lindén Hirschberg | 170 | 2020-12-18 | 2024-12-17 |
| Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol WO2085 Moisturising Cream, Estriol Cream 0.1% - Vulvovaginal Atrophy | Phase 4 | Completed | Dr. August Wolff GmbH & Co. KG Arzneimittel | 172 | 2016-11-01 | 2017-07-14 |
| Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA Ospemifene - Vulvovaginal Atrophy, Dyspareunia | Phase 4 | Completed | Sue Goldstein | 10 | 2015-07-01 | 2019-04-02 |
Breast Neoplasms (1) · Dyspareunia (1)
Breast Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Sexual Dysfunction, Physiological (1) · Sexual Dysfunctions, Psychological (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Urogenital Diseases (1)
Dehydroepiandrosterone (1) · Estrogens (1) · Ospemifene (1) · Probiotics (1)
Angelica Lindén Hirschberg (1) · Dr. August Wolff GmbH & Co. KG Arzneimittel (1) · Sue Goldstein (1) · University Hospital, Ghent (1)
Belgium (1) · Germany (1) · Sweden (1) · Switzerland (1) · United States (1)
Hans Verstraelen, MD, PhD (1) · Irwin Goldstein, MD (1) · Kirstin Deuble-Bente, MD (1) · Prof. Christoph Abels, MD, PhD (1) · Prof. Petra Stute, MD, PhD (1)
2016 (1)